A powerful tool to study metabolic reprogramming in pediatric cancers

Abstract

Johnston et al. developed an intra-operative U 13 C-glucose infusion protocol that is well tolerated by patients with pediatric cancers and shows cancer-type-specific metabolic alterations with therapeutical consequences. The development of this procedure and their findings will strongly benefit metabolic analysis of pediatric cancers and design of new therapeutic strategies.